Mechanisms of the effect of magnesium salts in preeclampsia

Placenta. 2018 Sep:69:134-139. doi: 10.1016/j.placenta.2018.04.011. Epub 2018 Apr 24.

Abstract

Preeclampsia is a heterogeneous pregnancy-specific syndrome associated with abnormal trophoblast invasion and endothelial dysfunction. Magnesium (Mg2+) level may be normal or decreased in women with preeclampsia. However, the use of Mg2+ salts, such as Mg2+ sulphate, are useful in reducing the pathophysiological consequences of preeclampsia with severe features and eclampsia. Although the mechanism of action of this Mg2+ salt is not well understood, the available evidence suggests a beneficial effect of Mg2+ for the mother and foetus. The mechanisms include a lower level of soluble fms-like tyrosine kinase 1 and endoglin, blockage of brain N-methyl-D-aspartate receptors, decreased inflammation mediators, activation of nitric oxide synthases, blockage of arginases, and reduced free radicals level. The maintenance of Mg2+ homeostasis in pregnancy is crucial for an appropriate pregnancy progression. Oral Mg2+ salts can be used for this purpose which could result in mitigating the deleterious consequences of this syndrome to the mother, foetus, and newborn.

Keywords: Eclampsia; Human; Magnesium; Magnesium salts; Placenta; Preeclampsia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Endothelium, Vascular / drug effects*
  • Female
  • Humans
  • Infant, Newborn
  • Magnesium / pharmacology
  • Magnesium / therapeutic use*
  • Placenta / drug effects*
  • Pre-Eclampsia / drug therapy*
  • Pregnancy
  • Treatment Outcome
  • Trophoblasts / drug effects

Substances

  • Magnesium